학술논문

Preventing Cardiotoxicity in Personalized Breast Irradiation.
Document Type
Article
Source
Cancers. Nov2023, Vol. 15 Issue 21, p5153. 10p.
Subject
*CARDIOTOXICITY
*LUNG volume measurements
*SIMULATION methods in education
*CANCER patients
*DOSE-response relationship (Radiation)
*COMPARATIVE studies
*DESCRIPTIVE statistics
*RADIOISOTOPE brachytherapy
*RECEIVER operating characteristic curves
*BREAST tumors
*BREATH holding
Language
ISSN
2072-6694
Abstract
Simple Summary: Adjuvant radiotherapy is a standard of care in the treatment of breast cancer patients after surgery, but irradiation of left-sided breast cancer showed a higher incidence of adverse cardiac effects, mainly for left descending artery (LAD) irradiation. The aim of the study was to assess the benefit of a deep inspiration breath hold (DIBH) over a standard irradiation technique. Patients received both standard and DIBH simulation. Data on 394 treatment plans (197 patients) were extracted and analyzed. The LAD dose was significantly reduced in DIBH plans with the maximum and mean dose reduced by 31.7% (mean value 3.5 Gy vs. 4.8 Gy, p ≤ 0.001) and 28.1% (mean value 8.2 Gy vs. 12.8 Gy, p ≤ 0.001) in DIBH plans compared to FB plans, underlying that patients could suffer less from irradiation cardiotoxicity with this technique. Background: This study aims to assess the benefit of a deep inspiration breath hold (DIBH) over the standard irradiation technique, and eventually to identify anatomical and/or treatment preplanning characteristics correlated with the LAD dose. Methods: Patients with left-sided breast cancer undergoing whole breast radiotherapy with DIBH were analyzed. All patients included in the analysis had plans in DIBH and free-breathing (FB). Receiving operating characteristics (ROC analysis) were used to identify the cut-off point of parameters to predict the LAD maximum dose > 10 Gy and LAD mean dose > 4 Gy, and the areas under the curve (AUCs) were computed. Post-test probability has been performed to evaluate the effect of parameters' combination. Results: One hundred ninety-seven patients were analyzed. The LAD dose was significantly reduced in DIBH plans with the maximum and mean dose reduced by 31.7% (mean value 3.5 Gy vs. 4.8 Gy, p ≤ 0.001) and 28.1% (mean value 8.2 Gy vs. 12.8 Gy, p ≤ 0.001) in DIBH plans compared to FB plans. The strongest predictor of the LAD dose (maximum > 10 Gy and mean > 4 Gy) was the minimum distance of LAD from tangent open fields. Other parameters were lung volume and heart volume (LAD Dmax > 10 Gy) and lung volume, heart volume, and breast separation (LAD Dmean > 4 Gy). Conclusion: The dosimetric advantage of DIBH is clear in all patients and DIBH should always be preferred. [ABSTRACT FROM AUTHOR]